SCHEMBL5850996

SCHEMBL5850996

CCOC(=O)[C@H](Cc1ccc(OC2CCN(C)CC2)cc1)NC(=O)C1(N(C)S(=O)(=O)c2ccc(C)cc2)CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 4/20 0.39
ITGB1 P05556 3/20 0.39
ACACB O00763 3/20 0.38
ALDH1A1 P00352 2/20 0.37
PKM P14618 1/20 0.37
ITGB7 P26010 1/20 0.37
HTR2A P28223 3/20 0.37
HTR2C P28335 3/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HRH1 P35367 2/20 0.36
CCR3 P51677 2/20 0.36
KCNH2 Q12809 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
HDAC3 O15379 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5852314 0.95 ITGB1 (0.40) ITGA4ITGB1ACACBALDH1A1ITGB7
SCHEMBL5850607 0.92 ITGA4 (0.47) ITGA4ITGB1ACACBALDH1A1ITGB7
SCHEMBL5850823 0.83 ITGB1 (0.42) ITGA4ITGB1ITGB7NPSR1L3MBTL1
SCHEMBL5851039 0.78 ATM (0.55) ITGA4ITGB1ALDH1A1ITGB7L3MBTL1
SCHEMBL5850641 0.78 ITGB1 (0.44) ITGA4ITGB1ALDH1A1ITGB7NPSR1
SCHEMBL7409938 0.76 ATM (0.55) ITGA4ITGB1ALDH1A1ITGB7NPSR1
SCHEMBL5850926 0.76 ALDH1A1 (0.45) ITGA4ITGB1ALDH1A1TP53ALOX15
SCHEMBL5850329 0.75 ITGB1 (0.41) ITGA4ITGB1ITGB7L3MBTL1
SCHEMBL5850545 0.75 ITGB1 (0.52) ITGA4ITGB1ITGB7
SCHEMBL5850857 0.74 ITGB1 (0.64) ITGA4ITGB1ALDH1A1ITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US disclosed
EP-0994895-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-04-26 EP disclosed
WO-1999006435-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed